| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/20/1992 | CA2088246A1 Gene encoding equine herpesvirus type i glycoprotein d, its gene product, antibodies and their uses |
| 02/20/1992 | CA2088164A1 Nuclear phosphoproteins for prognosticating lymphoid or epithelial cancers |
| 02/20/1992 | CA2087731A1 Novel polyamine conjugated oligonucleotides |
| 02/19/1992 | EP0471647A2 Restriction-deficient mutants |
| 02/19/1992 | EP0471564A2 Translational enhancement in pseudomonas |
| 02/19/1992 | EP0471514A2 Improved bacteriophage lambda pL promoters |
| 02/19/1992 | EP0471466A2 DNA sequences which impart resistance to the fungicide 8-chloro-4-(2-chloro-4-fluorophenoxy)quinoline |
| 02/19/1992 | EP0471457A2 Herpesvirus-based viral vector which expresses a foot & mouth disease virus epitope |
| 02/19/1992 | EP0471345A1 Determination of biogenous amines |
| 02/19/1992 | EP0471205A1 Monoclonal antibodies which bind TRK proto-oncogene protein |
| 02/19/1992 | EP0471056A1 Biosynthesis of carotenoids in genetically engineered hosts |
| 02/19/1992 | EP0471028A1 Highly cytopathogenic hiv-ndk retrovirus, dna fragments of this retrovirus, method for preparing a protein and/or an enzyme of this virus, and the applications of these |
| 02/19/1992 | EP0470999A1 Method and vectors for stabilizing heterologous protein expression |
| 02/19/1992 | EP0428518A4 Monoclonal antibodies specific for the harvey, kirsten and n ras proteins and their use as diagnostic reagents |
| 02/19/1992 | CN1058782A Epitheliins: novel cysteine-rich growth modulating proteins |
| 02/18/1992 | WO1992003478A1 Metal ion mediated receptor binding of polypeptide hormones |
| 02/18/1992 | US5089603 Antigenic epitopes present on membrane-bound but not secreted iga |
| 02/18/1992 | US5089473 Somatotropin variants and their use |
| 02/18/1992 | US5089408 Glutathione peroxidase gene and process for production of the gene product |
| 02/18/1992 | US5089406 Method of producing a gene cassette coding for polypeptides with repeating amino acid sequences |
| 02/18/1992 | US5089400 Recombinant DNA which produces lymphoblastoid interferon-like polypeptides, useful as immunomodulators |
| 02/18/1992 | US5089398 Enhanced yeast transcription employing hybrid GAPDH promoter region constructs |
| 02/18/1992 | US5089397 Superior mammalian expression system |
| 02/18/1992 | US5089396 Nucleic acid encoding β chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid |
| 02/18/1992 | US5089386 Test for listeria |
| 02/18/1992 | US5089262 Diagnosis, therapy |
| 02/18/1992 | CA2087267A1 Metal ion mediated receptor binding of polypeptide hormones |
| 02/18/1992 | CA1295960C Monoclonal antibody |
| 02/17/1992 | WO1992003455A1 INHIBITION OF $i(CANDIDA) |
| 02/17/1992 | CA2089665A1 Inhibition of candida |
| 02/17/1992 | CA2049188A1 Restriction-deficient mutant |
| 02/16/1992 | WO1992003563A1 Method for modifying the cell, tissue or host tropism of a microorganism; recombinant microorganisms obtained in this way and use thereof in medicine and veterinary medicine |
| 02/16/1992 | WO1992003051A1 Inhibition of herpesviridae infection by antisense oligonucleotides |
| 02/16/1992 | CA2089484A1 Method for modifying the cell tissue or host tropism of a microorganism; recombinant microorganisms obtained in this way and use thereof in medicine and veterinary medicine |
| 02/16/1992 | CA2089476A1 Inhibition of herpesviridae infection by antisense oligonucleotides |
| 02/16/1992 | CA2048244A1 Monoclonal antibodies which bind trk proto-oncogene protein |
| 02/15/1992 | WO1992003454A1 Inhibition of influenza virus type a, ann arbor strain h2n2 by antisense oligonucleotides |
| 02/15/1992 | WO1992003144A1 Protein structure of the plant toxin gelonin |
| 02/15/1992 | CA2089562A1 Inhibition of influenza virus type a, ann arbor strain h2n2 by antisense oligonucleotides |
| 02/14/1992 | WO1992003574A1 Cytokine production |
| 02/14/1992 | WO1992003561A1 HYBRID α-AMYLASE PROMOTERS |
| 02/14/1992 | WO1992003551A1 Birch pollen allergen p14 for diagnosis and therapy of allergic diseases |
| 02/14/1992 | WO1992003466A1 Lymphokine 154 |
| 02/14/1992 | WO1992003452A1 Novel nucleoside analogs |
| 02/14/1992 | CA2089389A1 Cytokine production |
| 02/14/1992 | CA2089258A1 Lymphokine 154 |
| 02/14/1992 | CA2088496A1 Recombinant bpi proteins, uses of bpi proteins, and methods of preparing same |
| 02/14/1992 | CA2086824A1 Hybrid.alpha.-amylase promoters |
| 02/14/1992 | CA2067182A1 Birch pollen allergen p14 for diagnosis and therapy of allergic diseases |
| 02/14/1992 | CA2048956A1 Bacteriophage lambda pl promoters |
| 02/13/1992 | DE3744928C2 Enzyme prodn. using bacterium contg. recombinant plasmids - using a host contg. enzyme genes and a control gene forming an apo-repressor |
| 02/12/1992 | EP0470604A2 PACAP38, proteine with adenylate cyclase activity |
| 02/12/1992 | EP0470586A1 Purified recombinant interleukin-2 compositions |
| 02/12/1992 | EP0470565A1 Peptides with antigenic determinant characteristic for alpha 1-microglobulin |
| 02/12/1992 | EP0470520A2 Process for the preparation of peptides or polypeptides in a cell-free translation system |
| 02/12/1992 | EP0470230A1 Method for obtaining and purifying the carboxyl-terminal fragment of the dna polymerase i of streptococcus pneunomiae |
| 02/12/1992 | EP0470165A1 Fusion proteins containing n-terminal fragments of human serum albumin |
| 02/12/1992 | EP0094428B1 Control of dna sequence transcription |
| 02/12/1992 | CN1058616A Cloning and overexpression of glucose-6-phosphate dehydrogenase from leuconostoc dextranicus |
| 02/12/1992 | CN1058597A Process for enzymatic preparation of basic fibroblast growth factor |
| 02/11/1992 | US5087617 Methods and compositions for treatment of cancer using oligonucleotides |
| 02/11/1992 | US5087615 Novel method of ovulation induction in humans |
| 02/11/1992 | US5087613 Hirudin variants |
| 02/11/1992 | US5087572 Anticoagulants |
| 02/11/1992 | US5087571 Culturing cells containing recombinant activated oncogene sequence |
| 02/11/1992 | US5087564 Preferential cleavage of an e coli rec a fusion protein at the clu-ser junction site of a heterologous peptide |
| 02/11/1992 | US5087560 Monoclonal antibody for use in drug resistant cancers and production thereof |
| 02/11/1992 | CA2048880A1 Dna and use thereof |
| 02/11/1992 | CA1295568C Cloning and utilization of aminotransferase genes |
| 02/11/1992 | CA1295567C Expression system for the secretion of bioactive human granulocyte, macrophage-colony stimulating factor (gm-csf) and other heterologous proteins from streptomyces |
| 02/11/1992 | CA1295566C Characterization and structure of genes for protease a and protease b from streptomyces griseus |
| 02/11/1992 | CA1295565C Enzyme deregulation |
| 02/11/1992 | CA1295564C Recombinant plasmid inserted with herpes simplex virus gene |
| 02/11/1992 | CA1295563C Production of active proteins containing cystine residues |
| 02/11/1992 | CA1295562C DNA SEQUENCES CODING FOR THE DR.beta.-CHAIN LOCUS OF THE HUMAN LYMPHOCYTE ANTIGEN COMPLEX AND POLYPEPTIDES, DIAGNOSTIC TYPING PROCESSES AND PRODUCTS RELATED THERETO |
| 02/11/1992 | CA1295561C Production of herpes simplex viral proteins |
| 02/11/1992 | CA1295558C Synthesis of long chain dna |
| 02/10/1992 | WO1992002641A1 Psoralen conjugated methylphosphonate oligonucleotides as therapeutic agents for chronic myelogenous leukemia |
| 02/10/1992 | WO1992002629A1 Producing monoclonal antibodies against human t-cell receptor elements using recombinant dna vectors |
| 02/10/1992 | WO1992002532A1 Improved non-nucleotide-based linker reagents for oligomers |
| 02/10/1992 | CA2089088A1 Psoralen conjugated methylphosphonate oligonucleotides as therapeutic agents for chronic myelogenous leukemia |
| 02/10/1992 | CA2089087A1 Non-nucleotide-based-linker reagents for oligomers |
| 02/10/1992 | CA2088905A1 Producing monoclonal antibodies against human t-cell receptor elements using recombinant dna vectors |
| 02/09/1992 | WO1992002640A1 Cannabinoid receptor |
| 02/09/1992 | WO1992002627A1 Corynebacteria integron, method of transformation of corynebacteria by said integron, and corynebacteria obtained |
| 02/09/1992 | WO1992002621A2 Allergens of alder pollen and applications thereof |
| 02/09/1992 | CA2087844A1 Cannabinoid receptor |
| 02/09/1992 | CA2067240A1 Corynebacterium integron, transformation process of a corynebacterium by said integron and corynebacterium thus obtained |
| 02/09/1992 | CA2067144A1 Allergens of alder pollen and applications thereof |
| 02/07/1992 | WO1992002638A1 Homogeneous assay system |
| 02/07/1992 | WO1992002549A1 Plasmodium falciparum antigen for eliciting protective antibodies for use in vaccines |
| 02/07/1992 | CA2088988A1 Plasmodium falciparum antigen for eliciting protective antibodies for use in vaccines |
| 02/07/1992 | CA2048305A1 Peptides with a characteristic antigenic determinant for alphal-microglobulin |
| 02/06/1992 | WO1992001936A1 Assay of free and complexed prostate-specific antigen (psa) |
| 02/06/1992 | WO1992001814A2 The reduction of non-specific amplification during in vitro nucleic acid amplification using modified nucleic acid bases |
| 02/06/1992 | WO1992001812A1 Competitive pcr for quantitation of dna |
| 02/06/1992 | WO1992001810A1 Methods of identifying compounds that act as agonists or antagonists for proteins involved in signal transduction |
| 02/06/1992 | WO1992001806A1 Selection of ribozymes that efficiently cleave target rna |
| 02/06/1992 | WO1992001802A1 Methods and apparatus for ice-medicated introduction of substances into biological material in a non-lethal manner |
| 02/06/1992 | WO1992001800A1 Method for integrative transformation of yeast using dispersed repetitive elements |